Artal Group as of Sept. 30, 2020
Portfolio Holdings for Artal Group
Artal Group holds 133 positions in its portfolio as reported in the September 2020 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ) | 13.9 | $572M | 2.1M | 277.84 | |
Ww Intl (WW) | 6.8 | $280M | 15M | 18.87 | |
Beigene Sponsored Adr (BGNE) | 6.3 | $258M | 900k | 286.44 | |
Goldman Sachs Call Option (GS) | 4.3 | $176M | 875k | 200.97 | |
Acceleron Pharma | 3.8 | $158M | 1.4M | 112.53 | |
Alibaba Group Hldg Sponsored Ads (BABA) | 3.0 | $125M | 425k | 293.98 | |
Biontech Se Sponsored Ads (BNTX) | 2.9 | $120M | 1.7M | 69.23 | |
Alnylam Pharmaceuticals (ALNY) | 2.8 | $117M | 800k | 145.60 | |
JPMorgan Chase & Co. Call Option (JPM) | 2.3 | $96M | 1.0M | 96.27 | |
Generation Bio (GBIO) | 2.1 | $87M | 2.8M | 30.91 | |
Lexicon Pharmaceuticals Com New (LXRX) | 2.1 | $87M | 60M | 1.44 | |
Argenx Se Sponsored Adr (ARGX) | 2.1 | $85M | 324k | 262.52 | |
Mirati Therapeutics | 2.0 | $83M | 500k | 166.05 | |
GDS HLDGS Sponsored Ads (GDS) | 2.0 | $82M | 1.0M | 81.83 | |
Allovir (ALVR) | 1.6 | $64M | 2.3M | 27.50 | |
Fate Therapeutics (FATE) | 1.5 | $60M | 1.5M | 39.97 | |
Amicus Therapeutics (FOLD) | 1.4 | $57M | 4.0M | 14.12 | |
Ke Hldgs Sponsored Ads (BEKE) | 1.3 | $53M | 870k | 61.30 | |
Igm Biosciences (IGMS) | 1.2 | $51M | 689k | 73.81 | |
Bank of America Corporation Call Option (BAC) | 1.2 | $48M | 2.0M | 24.09 | |
Black Diamond Therapeutics (BDTX) | 1.1 | $46M | 1.5M | 30.23 | |
Morphic Hldg (MORF) | 1.1 | $45M | 1.7M | 27.34 | |
Scholar Rock Hldg Corp (SRRK) | 1.1 | $44M | 2.5M | 17.69 | |
Abbvie Call Option (ABBV) | 1.1 | $44M | 500k | 87.59 | |
Schrodinger (SDGR) | 1.0 | $43M | 897k | 47.51 | |
Tg Therapeutics (TGTX) | 1.0 | $40M | 1.5M | 26.76 | |
Select Sector Spdr Tr Sbi Int-inds Call Option (XLI) | 0.9 | $39M | 500k | 76.98 | |
I Mab Sponsored Ads (IMAB) | 0.8 | $34M | 725k | 47.03 | |
Novagold Res Com New (NG) | 0.8 | $31M | 2.6M | 11.89 | |
Deciphera Pharmaceuticals (DCPH) | 0.7 | $31M | 600k | 51.30 | |
Gossamer Bio (GOSS) | 0.7 | $29M | 2.4M | 12.41 | |
Atara Biotherapeutics (ATRA) | 0.7 | $29M | 2.3M | 12.96 | |
Albireo Pharma | 0.7 | $28M | 851k | 33.37 | |
Turning Point Therapeutics I | 0.7 | $28M | 325k | 87.36 | |
Uniqure Nv SHS (QURE) | 0.7 | $28M | 750k | 36.83 | |
Agenus Com New (AGEN) | 0.7 | $28M | 6.9M | 4.00 | |
Iteos Therapeutics (ITOS) | 0.7 | $27M | 1.1M | 24.67 | |
Taysha Gene Therapies Com Shs (TSHA) | 0.6 | $26M | 1.1M | 22.40 | |
Morgan Stanley Com New Call Option (MS) | 0.6 | $24M | 500k | 48.35 | |
Apple Call Option (AAPL) | 0.6 | $23M | 200k | 115.81 | |
Citigroup Com New Call Option (C) | 0.5 | $22M | 500k | 43.11 | |
Trillium Therapeutics Com New | 0.5 | $21M | 1.5M | 14.21 | |
Moderna (MRNA) | 0.5 | $21M | 300k | 70.75 | |
Stoneco Com Cl A (STNE) | 0.5 | $21M | 400k | 52.89 | |
Zillow Group Cl C Cap Stk (Z) | 0.5 | $20M | 200k | 101.59 | |
Translate Bio | 0.5 | $19M | 1.4M | 13.61 | |
Rubius Therapeutics | 0.5 | $19M | 3.8M | 5.01 | |
Mersana Therapeutics (MRSN) | 0.5 | $19M | 1.0M | 18.62 | |
Adverum Biotechnologies | 0.5 | $19M | 1.8M | 10.30 | |
Trip Com Group Ads (TCOM) | 0.4 | $18M | 570k | 31.14 | |
Repare Therapeutics Ord (RPTX) | 0.4 | $18M | 570k | 30.77 | |
Relay Therapeutics (RLAY) | 0.4 | $17M | 400k | 42.59 | |
Kura Oncology (KURA) | 0.4 | $17M | 549k | 30.64 | |
Danaher Corporation (DHR) | 0.4 | $16M | 75k | 215.33 | |
Replimune Group (REPL) | 0.4 | $16M | 700k | 23.02 | |
Fibrogen (FGEN) | 0.4 | $16M | 380k | 41.12 | |
Bridgebio Pharma (BBIO) | 0.4 | $15M | 400k | 37.52 | |
Bio-techne Corporation (TECH) | 0.4 | $15M | 60k | 247.73 | |
Immunic (IMUX) | 0.4 | $15M | 800k | 18.57 | |
General Motors Company Call Option (GM) | 0.4 | $15M | 500k | 29.59 | |
Aurinia Pharmaceuticals (AUPH) | 0.4 | $15M | 1.0M | 14.73 | |
Ovid Therapeutics (OVID) | 0.3 | $14M | 2.5M | 5.74 | |
Denali Therapeutics (DNLI) | 0.3 | $14M | 400k | 35.83 | |
Harpoon Therapeutics | 0.3 | $14M | 800k | 16.99 | |
Sage Therapeutics (SAGE) | 0.3 | $14M | 222k | 61.12 | |
Springworks Therapeutics (SWTX) | 0.3 | $14M | 285k | 47.67 | |
Metacrine Ord | 0.3 | $13M | 1.3M | 10.21 | |
Iovance Biotherapeutics (IOVA) | 0.3 | $13M | 400k | 32.92 | |
Cardiff Oncology (CRDF) | 0.3 | $13M | 900k | 14.19 | |
Epizyme | 0.3 | $12M | 1.0M | 11.93 | |
BioMarin Pharmaceutical Call Option (BMRN) | 0.3 | $11M | 150k | 76.08 | |
Selecta Biosciences (RNAC) | 0.3 | $11M | 4.5M | 2.48 | |
Cyclerion Therapeutics | 0.3 | $11M | 1.8M | 6.06 | |
Y Mabs Therapeutics (YMAB) | 0.3 | $11M | 285k | 38.39 | |
Royalty Pharma Shs Class A (RPRX) | 0.3 | $11M | 250k | 42.07 | |
Krystal Biotech (KRYS) | 0.2 | $10M | 238k | 43.05 | |
Tcr2 Therapeutics Inc cs | 0.2 | $10M | 500k | 20.32 | |
Esperion Therapeutics (ESPR) | 0.2 | $9.3M | 250k | 37.17 | |
Stoke Therapeutics (STOK) | 0.2 | $9.1M | 271k | 33.49 | |
Seres Therapeutics (MCRB) | 0.2 | $8.5M | 300k | 28.31 | |
Kymera Therapeutics (KYMR) | 0.2 | $8.1M | 250k | 32.31 | |
Applied Therapeutics (APLT) | 0.2 | $7.9M | 380k | 20.76 | |
Dyne Therapeutics (DYN) | 0.2 | $7.5M | 370k | 20.19 | |
Aeglea Biotherapeutics | 0.2 | $7.4M | 1.0M | 7.09 | |
Pmv Pharmaceuticals (PMVP) | 0.2 | $7.1M | 200k | 35.50 | |
Bruker Corporation (BRKR) | 0.2 | $7.0M | 175k | 39.75 | |
Spero Therapeutics (SPRO) | 0.2 | $6.7M | 600k | 11.16 | |
Aravive | 0.1 | $6.2M | 1.3M | 4.70 | |
American Airls Call Option (AAL) | 0.1 | $6.1M | 500k | 12.29 | |
Regenxbio Inc equity us cm (RGNX) | 0.1 | $6.1M | 222k | 27.52 | |
Proqr Thrapeutics N V Shs Euro (PRQR) | 0.1 | $5.7M | 1.2M | 4.79 | |
Hookipa Pharma Inc equity (HOOK) | 0.1 | $5.7M | 600k | 9.47 | |
Leap Therapeutics | 0.1 | $5.6M | 2.8M | 1.98 | |
Kaleido Biosciences Ord (KLDO) | 0.1 | $5.5M | 501k | 11.07 | |
Alpine Immune Sciences (ALPN) | 0.1 | $5.2M | 593k | 8.79 | |
Aptinyx | 0.1 | $5.1M | 1.5M | 3.38 | |
Vaxart Com New (VXRT) | 0.1 | $5.0M | 750k | 6.65 | |
Ac Immune Sa SHS (ACIU) | 0.1 | $4.9M | 1.0M | 4.88 | |
Adaptive Biotechnologies Cor (ADPT) | 0.1 | $4.9M | 100k | 48.63 | |
Accelr8 Technology | 0.1 | $4.6M | 428k | 10.66 | |
Syros Pharmaceuticals | 0.1 | $4.1M | 466k | 8.84 | |
111 Ads (YI) | 0.1 | $4.0M | 650k | 6.20 | |
Avidity Biosciences Ord (RNA) | 0.1 | $4.0M | 143k | 28.15 | |
Intellia Therapeutics (NTLA) | 0.1 | $3.8M | 190k | 19.88 | |
Alx Oncology Hldgs (ALXO) | 0.1 | $3.8M | 100k | 37.74 | |
Occidental Petroleum Corporation (OXY) | 0.1 | $3.8M | 375k | 10.01 | |
Oric Pharmaceuticals (ORIC) | 0.1 | $3.6M | 143k | 25.01 | |
Prothena Corp SHS (PRTA) | 0.1 | $3.5M | 352k | 9.99 | |
Solid Biosciences | 0.1 | $3.5M | 1.7M | 2.03 | |
Autolus Therapeutics Sponsored Ads (AUTL) | 0.1 | $3.3M | 285k | 11.64 | |
Axcella Health Inc equity | 0.1 | $3.3M | 713k | 4.62 | |
Adc Therapeutics Sa SHS (ADCT) | 0.1 | $3.1M | 95k | 32.99 | |
Prevail Therapeutics Ord | 0.1 | $3.1M | 303k | 10.18 | |
Merus N V (MRUS) | 0.1 | $3.0M | 250k | 12.00 | |
Zentalis Pharmaceuticals (ZNTL) | 0.1 | $2.9M | 87k | 32.69 | |
Protagonist Therapeutics (PTGX) | 0.1 | $2.6M | 133k | 19.55 | |
Evelo Biosciences | 0.1 | $2.5M | 475k | 5.27 | |
Minerva Neurosciences | 0.1 | $2.4M | 760k | 3.18 | |
Mei Pharma Com New | 0.1 | $2.4M | 760k | 3.12 | |
Aduro Biotech | 0.1 | $2.2M | 903k | 2.43 | |
Pandion Therapeutics | 0.0 | $1.7M | 145k | 11.46 | |
Curis Com New | 0.0 | $1.6M | 1.4M | 1.17 | |
Chiasma | 0.0 | $1.6M | 380k | 4.30 | |
Adicet Bio (ACET) | 0.0 | $1.5M | 129k | 11.89 | |
Select Sector Spdr Tr Energy Call Option (XLE) | 0.0 | $1.5M | 50k | 29.96 | |
Orchard Therapeutics Ads | 0.0 | $1.4M | 352k | 4.11 | |
Cytomx Therapeutics (CTMX) | 0.0 | $1.2M | 179k | 6.65 | |
Bellus Health Com New | 0.0 | $1.1M | 475k | 2.27 | |
Ironwood Pharmaceuticals Com Cl A (IRWD) | 0.0 | $994k | 111k | 8.99 | |
Rigel Pharmaceuticals Com New (RIGL) | 0.0 | $771k | 321k | 2.40 | |
Cidara Therapeutics Inc Common Stock Usd 0.0001 (CDTX) | 0.0 | $640k | 225k | 2.85 | |
Passage Bio (PASG) | 0.0 | $205k | 16k | 13.10 | |
Ideaya Biosciences (IDYA) | 0.0 | $0 | 8.00 | 0.00 |